
Golden Seeds
Description
Golden Seeds is a prominent early-stage investment firm based in the United States, uniquely dedicated to funding women-led businesses. Established in 2005, the firm operates with a mission to identify and support high-growth companies founded or co-founded by women, addressing the significant funding gap often faced by female entrepreneurs. While headquartered in New York, Golden Seeds leverages a broad network of angel investors across various chapters, including Boston and Silicon Valley, to source and evaluate opportunities. Their investment thesis spans diverse sectors, including B2B SaaS, enterprise technology, consumer products, healthtech, and fintech, demonstrating a versatile approach to market opportunities.
The firm primarily focuses on seed to early-stage investments, providing crucial capital during the formative years of a startup. Golden Seeds is known for its hands-on approach, often offering strategic guidance and leveraging its extensive network to help portfolio companies scale. Since its inception, Golden Seeds has made a substantial impact on the entrepreneurial landscape, having invested over $140 million across more than 200 companies. This significant capital deployment underscores their commitment to fostering a more inclusive and equitable venture ecosystem.
Golden Seeds typically provides initial investments ranging from $250,000 to $1 million. This initial cheque size is designed to help early-stage companies achieve critical milestones, such as product development, market validation, and initial customer acquisition. Beyond the initial investment, Golden Seeds also considers follow-on funding rounds for their most promising portfolio companies, demonstrating a long-term commitment to their success. Their model combines the rigor of a venture fund with the collaborative spirit of an angel network, making them a distinctive player in the early-stage investment landscape focused on diversity.
Investor Profile
Golden Seeds has backed more than 114 startups, with 0 new investments in the last 12 months alone. The firm has led 29 rounds, about 25% of its total and boasts 13 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Seed, Series B rounds (top funding stages).
- Majority of deals are located in United States, Canada.
- Strong thematic focus on Health Care, Biotechnology, Software.
- Typical check size: $250K – $1M.
Stage Focus
- Series A (37%)
- Seed (32%)
- Series B (13%)
- Series Unknown (7%)
- Series C (5%)
- Angel (2%)
- Pre Seed (2%)
- Private Equity (2%)
- Series D (1%)
Country Focus
- United States (99%)
- Canada (1%)
Industry Focus
- Health Care
- Biotechnology
- Software
- Medical Device
- Medical
- Saas
- Therapeutics
- E-commerce
- Artificial Intelligence (Ai)
- Information Technology
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.